Corteva, Inc. (NYSE:CTVA) Shares Bought by American Century Companies Inc.

American Century Companies Inc. raised its position in Corteva, Inc. (NYSE:CTVA - Free Report) by 4.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 131,538 shares of the company's stock after purchasing an additional 6,040 shares during the quarter. American Century Companies Inc.'s holdings in Corteva were worth $7,492,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in CTVA. Oak Thistle LLC bought a new stake in shares of Corteva during the 4th quarter worth approximately $1,514,000. Van ECK Associates Corp lifted its position in shares of Corteva by 5.9% during the fourth quarter. Van ECK Associates Corp now owns 9,428,206 shares of the company's stock worth $537,031,000 after purchasing an additional 525,531 shares during the last quarter. Swedbank AB lifted its position in shares of Corteva by 51.9% during the fourth quarter. Swedbank AB now owns 695,641 shares of the company's stock worth $39,624,000 after purchasing an additional 237,764 shares during the last quarter. Assenagon Asset Management S.A. grew its holdings in shares of Corteva by 755.8% in the fourth quarter. Assenagon Asset Management S.A. now owns 552,769 shares of the company's stock worth $31,486,000 after purchasing an additional 488,181 shares during the last quarter. Finally, S.E.E.D. Planning Group LLC grew its holdings in shares of Corteva by 54.5% in the fourth quarter. S.E.E.D. Planning Group LLC now owns 96,103 shares of the company's stock worth $5,474,000 after purchasing an additional 33,886 shares during the last quarter. Institutional investors own 81.54% of the company's stock.

Remove Ads

Corteva Stock Down 9.2 %

Shares of CTVA stock traded down $5.64 during trading hours on Friday, reaching $55.66. 6,391,602 shares of the company's stock were exchanged, compared to its average volume of 3,244,036. Corteva, Inc. has a fifty-two week low of $50.01 and a fifty-two week high of $66.24. The stock's 50 day moving average is $62.36 and its 200-day moving average is $60.26. The company has a current ratio of 1.45, a quick ratio of 0.93 and a debt-to-equity ratio of 0.08. The company has a market cap of $38.02 billion, a price-to-earnings ratio of 43.15, a P/E/G ratio of 1.68 and a beta of 0.73.

Corteva (NYSE:CTVA - Get Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. Analysts predict that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were paid a dividend of $0.17 per share. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $0.68 annualized dividend and a dividend yield of 1.22%. Corteva's payout ratio is currently 52.71%.

Insider Activity

In related news, insider Brian Titus sold 26,560 shares of the company's stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $63.74, for a total value of $1,692,934.40. Following the sale, the insider now owns 11,347 shares in the company, valued at $723,257.78. This represents a 70.07 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.14% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have commented on CTVA shares. Wells Fargo & Company upped their target price on shares of Corteva from $67.00 to $73.00 and gave the stock an "overweight" rating in a research note on Tuesday, January 28th. Citigroup increased their price objective on Corteva from $69.00 to $74.00 and gave the stock a "buy" rating in a research note on Wednesday, January 29th. Bank of America lifted their target price on Corteva from $69.00 to $73.00 and gave the company a "buy" rating in a research report on Tuesday, February 11th. Royal Bank of Canada increased their price target on Corteva from $72.00 to $73.00 and gave the stock an "outperform" rating in a research report on Friday, February 7th. Finally, KeyCorp lifted their price objective on Corteva from $68.00 to $70.00 and gave the company an "overweight" rating in a report on Friday, February 7th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and fourteen have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $68.06.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.